FDA Panel Strongly Endorses Oceana's Solesta Fecal Incontinence Product
This article was originally published in The Gray Sheet
Executive Summary
An FDA advisory panel offered strong support Dec. 2 to Ocean Therapeutics' effort to win PMA approval for its Solesta injectable bulking agent for fecal incontinence.
You may also be interested in...
Oceana To Launch Solesta For Fecal Incontinence By September
Oceana Therapeutics plans to double its sales force over the summer by hiring 10 additional reps in preparation for a September launch of its newly approved Solesta bulking agent for fecal incontinence.
Oceana To Launch Solesta For Fecal Incontinence By September
Oceana Therapeutics plans to double its sales force over the summer by hiring 10 additional reps in preparation for a September launch of its newly approved Solesta bulking agent for fecal incontinence.
Research In Brief
Small AAA: Routine repair not advised